Drug Treatment of Schizophrenia: State of the Art and the Potential of the Atypical Neuroleptics

Hans-Jürgen Möller
  • January 2002, Springer Science + Business Media
  • DOI: 10.1007/978-3-7091-6148-7_14

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/978-3-7091-6148-7_14

The following have contributed to this page: Hans-Juergen Moeller